Every article, presentation, spotlight, and news item we've tagged to Regenerative Therapies.
Scientists have discovered how to rebuild your cells' protective caps—telomeres—that shorten with age. New research shows telomerase activation can reduce inflammation by 62% and measurably reverse cellular aging markers.
Bioregulator peptides are short-chain amino acid sequences designed to support tissue-specific gene expression that naturally declines with age. Longevity educator Nathalie Niddam explains how personalized peptide strategies, built on solid foundations, may help restore the body's own regulatory signals.
Stem cell scientist Christian Drapeau, founder of Stemregen, reframes everything you thought you knew about stem cells. Moving beyond injections and clinical treatments, this session reveals stem cells as your body's continuous repair system—regenerating your skin monthly, your liver every few years, and even your heart over decades. Drapeau explains how declining stem cell production beginning in our 30s creates cellular deficits that drive aging, and introduces the science of endogenous stem cell mobilization: triggering your bone marrow to release more of your body's own regenerative cells for natural tissue repair and longevity optimization.
Join pioneering stem cell scientist Christian Drapeau, creator of the first stem cell supplement, as he reveals how to unlock your body's natural regenerative potential. Discover the breakthrough science of endogenous stem cell mobilization (ESCM) and learn practical strategies to harness your own stem cells for tissue repair and longevity. Drapeau will share insights from his groundbreaking work at Stemregen on how targeted supplementation can amplify your body's innate ability to heal itself, offering a revolutionary approach to health optimization that works with your biology, not against it.
Discover why measuring intracellular NAD+ levels transforms guesswork into precision optimization, helping you maintain cellular energy and vitality decades longer.
Stem cell availability declines with age, leaving tissues that once healed quickly struggling to repair. Discover how specific botanicals can increase circulating stem cells by up to 80%, restoring your body's natural renewal capacity.
Discover the cutting-edge science behind telomeres—the protective DNA caps that determine cellular aging and lifespan. Sebastian Conti from T.A. Sciences reveals how these molecular timekeepers influence longevity and explores evidence-based strategies to support telomere health. From understanding the latest research on telomere biology to practical interventions that may slow cellular aging, this session provides actionable insights for health optimization. Learn why telomeres are considered the holy grail of aging research and how you can potentially influence your own cellular clock for enhanced healthspan and longevity.
Your body already contains the machinery for regeneration. Researchers are now exploring how perinatal birth tissues, rich in growth factors, extracellular vesicles, and matrix, may hold clues to restoring the repair capacity that declines with age.
Longevity educator and podcaster Nathalie Niddam explores bioregulators—tiny peptide chains that penetrate directly into cells to activate DNA repair and restore gene expression. Drawing from the groundbreaking work of Professor Khavinson's peptide theory of aging, this session demystifies how these two-to-four amino acid complexes differ from conventional peptides, why they don't need receptors to work, and how they address aging at the cellular motherboard. Niddam shares her favorite six "desert island" bioregulators and explains their role in a comprehensive longevity strategy, while navigating the evolving regulatory landscape and distinguishing between synthetic and animal-derived formulations.
What if aging isn't the inevitable decline we've been told it is? Dr. Ian White, regenerative medicine pioneer and founder of Neobiosis, challenges conventional thinking about biological aging by exploring nature's most radical examples—from immortal jellyfish that reverse their age to lobsters that never age at all. Drawing on two decades of stem cell research at Harvard, Cornell, and beyond, he presents compelling evidence that aging can be accelerated, slowed, paused, and even reversed. This provocative session examines the mechanisms behind age reversal, from Yamanaka factors to perinatal tissues, and explores whether regenerative medicine holds the key to treating aging itself as a disease.
Aeon Clinic in Dubai offers intravenous NAD+ supplementation and micronutrient delivery, claiming support for metabolic function, DNA repair, and cognitive clarity through direct bloodstream administration. The clinical model emphasizes physician oversight and personalized protocols as distinguishing factors in the premium wellness space.
A partnership between AcCELLerated Biologics and Forever Labs enables individuals to collect and cryopreserve their own adult stem cells while younger, creating a biological reserve for potential future regenerative therapies. This model shifts healthcare from reactive disease management toward proactive preservation of regenerative capacity during optimal biological windows.
AcCELLerated Biologics and Forever Labs have partnered to integrate adult stem cell banking with autologous biologic therapies, combining PRP, adipose, and exosome products with cryopreserved stem cell services. This positions clinicians to offer patients access to preserved youthful stem cells for personalized regenerative medicine and sustained healthspan support.
Cellular senescence—the accumulation of cells that cease dividing but resist death—has emerged as a primary target in longevity medicine due to evidence that clearing these cells extends healthspan and can address root causes of age-related disease. Senotherapeutics, including senolytics and senomorphics, are transitioning from preclinical studies to clinical trials, though significant challenges in biomarker standardization, cellular heterogeneity, and clinical efficacy remain.
Senolytic treatment with dasatinib and quercetin in aged mice produced measurable remodeling across immune, fibrotic, and metabolic pathways, with sustained intervention showing greater efficacy than short-term exposure. This work maps the molecular cascades underlying senolytic action and establishes timing as a critical variable in cellular rejuvenation.
AEON Clinic in Dubai offers physician-supervised IV nutrient therapies and NAD+ treatments as part of a broader shift toward personalized health optimization focused on healthspan rather than lifespan. The clinic positions these interventions within longer-term health strategies rather than as standalone wellness experiences, reflecting emerging sophistication in how longevity medicine is being integrated into clinical practice.
A preclinical study combining senescent cell clearance with stem cell-based regenerative therapy produced 70% lifespan extension in aged models, substantially outperforming either approach alone. The finding reinforces that addressing aging requires simultaneous intervention across multiple biological pathways rather than single-target strategies.
Therapeutic plasma exchange reduced circulating microplastics by approximately 60% in patients with elevated baseline levels, achieving statistical significance (p < 0.001). This represents the first clinical evidence that a mechanical intervention can effectively remove microplastic particles from human blood.
Senotherapeutics—strategies that eliminate or reprogram senescent cells—represent a shift from broad-spectrum senolytic approaches toward precision interventions that target specific cell types and contexts. This progression directly addresses a fundamental mechanism of aging, offering potential to extend healthspan by restoring cellular function rather than relying solely on senescent cell elimination.
Klothonova has completed a GMP-grade master cell bank of cells engineered to overexpress α-Klotho protein, advancing toward regulatory approval for an encapsulated cell therapy targeting aging and age-related disease. α-Klotho restoration represents a direct intervention in fundamental aging mechanisms that affect kidney function, neurodegeneration, and vascular integrity.
Researchers encapsulated healthy mitochondria in red blood cell membranes to deliver them into diseased cells, achieving efficient uptake and functional restoration across multiple cellular models of mitochondrial dysfunction. This addresses a long-standing barrier in mitochondrial replacement therapy and demonstrates potential for treating mitochondrial diseases and age-related energy decline.
Avaí Bio will present clinical data on an encapsulated cell therapy designed to restore circulating α-Klotho, a protein implicated in aging and metabolic regulation. The approach uses Austrianova's Cell-in-a-Box technology to sustain Klotho production, addressing a mechanism that declines with age and correlates with multiple age-related pathologies.
Klothea Bio has initiated a Phase 1b trial of AKL003, an mRNA therapy designed to elevate circulating alpha klotho protein levels in healthy adults. The trial represents a direct approach to testing whether increased klotho—a protein associated with organ protection and repair across multiple physiological systems—can favorably shift biomarkers linked to human lifespan and biological age.
Springfield Wellness Center has operated for 25 years using intravenous NAD+ therapy as part of a multimodal protocol for addiction recovery and brain restoration. The clinic's longevity and expansion suggest sustained clinical utility, though the evidence base and mechanistic clarity for NAD+ infusions in longevity contexts remain limited.
Immorta Bio's combined senolytic immunotherapy and regenerative cellular platform produced over 70% lifespan extension in aged animal models, alongside improvements in organ function, tissue repair, and markers of cellular recovery. The finding demonstrates that simultaneous clearance of senescent cells and activation of regenerative capacity can produce measurable gains in both lifespan and healthspan across multiple physiological domains.
Viome's acquisition of Circulate Health integrates therapeutic plasma exchange (TPE) into a diagnostic-to-intervention platform, positioning precision biomarker measurement alongside a clinical delivery mechanism for removing circulating microplastics and other inflammatory markers. The combined model addresses a structural limitation in diagnostics-heavy health tech: the ability to measure dysfunction without the infrastructure to remediate it.
Peptides represent a therapeutic class with genuine biological activity, requiring the same scrutiny applied to pharmaceutical interventions rather than supplements. The distinction between evidence-supported peptide applications and marketed claims determines whether they function as targeted tools or sources of unquantified risk.
Klothonova is developing an encapsulated cell therapy designed to restore circulating α-Klotho, a protein that declines with age and influences cardiovascular, renal, and cognitive function. The approach uses genetically modified cells housed in a biocompatible capsule to sustainably produce the protein, addressing a mechanism implicated in multiple age-related conditions.
A systematic review and meta-analysis of allogeneic mesenchymal stromal cell therapies for diabetic foot ulcers found higher rates of complete wound closure and greater reductions in wound size compared to standard care, with no clear signal of serious treatment-related adverse events. The work demonstrates that regenerative cell therapies may support the body's repair capacity when conventional approaches alone prove insufficient in metabolic disease.
A correction to published research on senolytics—drugs that selectively eliminate senescent cells—clarifies dosing and outcome measures in aged mice infected with influenza. The findings support senolytics as a tool for reducing both acute and chronic inflammatory responses in aged lungs, with direct relevance to infection susceptibility in aging.
Cenegenics has introduced selective plasma exchange technology designed to remove inflammatory proteins, metabolic byproducts, and environmental toxins while preserving beneficial plasma components. The service positions itself as a preventative intervention for individuals managing chronic environmental exposures and systemic inflammation.
Mitrix Bio has reported preliminary Phase 1 safety data from mitochondrial transplantation in two older adults with no observed adverse effects, while simultaneously launching clinics offering the intervention under Right to Try frameworks. This represents a transition from preclinical work to early clinical deployment, though data density remains limited relative to narrative momentum.
A dual-therapy approach combining senescent cell clearance with mesenchymal stem cell restoration produced a 70% lifespan extension in mice, accompanied by sustained improvements in physiological function. This preclinical result demonstrates that coordinated interventions targeting cellular aging and tissue regeneration can produce measurable longevity gains.
BCL XL-PROTAC, a senolytic agent, selectively eliminates senescent cells in COPD airway tissue while promoting proliferation of healthy cells. This approach addresses a core driver of age-related lung disease and suggests a therapeutic pathway for restoring lung cell function in COPD patients.
